- Stories /
- Healthcare /
- SaniSure /
Created one of the largest independent single-use solutions platforms in the bioprocessing industry through innovation and buy-and-build
2019 – Current
Good to great
c.50%
sales CAGR 2020-2022Launching innovative, proprietary solutions serving high-value customer needs in critical process steps
5
acquisitions completed in the first 12 monthsCompleted five acquisitions in first 12 months to form the global platform, accelerating each acquired business’s international growth
>1,000
pharmaceutical, CDMO and biotech customersIncreasing portfolio exposure to the high-growth biologics and cell and gene therapy markets
Investing to support commercial and operational excellence initiatives to better serve our customers